Skip to main content Accessibility help
×
Home
Hostname: page-component-cf9d5c678-xvx2z Total loading time: 0.142 Render date: 2021-08-02T04:00:48.715Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Article contents

Inhaled Loxapine for The Treatment of agitation in Borderline Personality Disorder

Published online by Cambridge University Press:  23 March 2020

R. Puente
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
M.F. Rabito alcon
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
S. Garcìa Jorge
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
H. Dolengevich Segal
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
M. Benítez alonso
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
J. Gómez- arnau Ramírez
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
a. Garrido Beltrán
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
J. Rodríguez Quirós
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
B. Unzeta Conde
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
O. Pecero García
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
J. Correas Lauffer
Affiliation:
Hospital Henares, Psychiatry, Madrid, Spain
Get access

Abstract

Introduction

inhaled loxapine has shown efficiency in the treatment of the mild-moderate agitation syndrome of schyzophrenia and mania patients. Its rapid response and calming effect non-sedative allow to hypothesize reasonable efficiency and tolerability in borderline personality disorder diagnosed patients.

aims

analyze the efficiency and tolerability of inhaled loxapine as a pharmacological approach in the treatment of agitation in borderline personality disorder (BPD) clinical diagnosed patients.

Materials and method

an application was administered for every agitation episode in BPD patients treated with inhaled loxapine in the emergency room or the psychiatric ward, which included B aRS and CGI-S scales for the evaluation of each episode and its severity, before and after its use. Other secondary measures of efficiency were taken into account, such as requirement of physical restrain.

Results

in the majority of evaluated episodes inhaled loxapine decreased notably initial B aRS and CGI-S values and no serious clinical side effects attributable to this medication were observed.

Conclusion

in our sample, inhaled loxapine was efficiency and well tolerated pharmacological intervention for agitation in BPD patients.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV630
Copyright
Copyright © European Psychiatric Association 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Submit a response

Comments

No Comments have been published for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Inhaled Loxapine for The Treatment of agitation in Borderline Personality Disorder
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Inhaled Loxapine for The Treatment of agitation in Borderline Personality Disorder
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Inhaled Loxapine for The Treatment of agitation in Borderline Personality Disorder
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *